Condition: Chronic Lymphocytic Leukemia (CLL) · Small Lymphocytic Lymphoma (SLL) · Sponsor: Nurix Therapeutics, Inc.
This is a study for patients with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who have previously received treatment with a BTK inhibitor (covalent and non-covalent) and a BCL-2 inhibitor. The main purpose of this study is to test if NX-5948 (bexobrutideg) works to treat patients with CLL/SLL. Participation could last up to 5 years, and possibly longer, if the disease does not progress.
This description comes directly from the study's public registry record.
Additional Site Contact Information · 415-417-3418 · clinicaltrials@nurixtx.com
Always discuss trial participation with your own doctor first.
| City of Hope | Duarte, California, United States | Recruiting |
| Colorado Blood Institute | Denver, Colorado, United States | Recruiting |
| University of Miami | Coral Gables, Florida, United States | Recruiting |
| Florida Cancer Specialists | Sarasota, Florida, United States | Recruiting |
| Fort Wayne Oncology and Hematology | Fort Wayne, Indiana, United States | Recruiting |
| Hematology Oncology of Indiana | Indianapolis, Indiana, United States | Recruiting |
| University of Iowa | Iowa City, Iowa, United States | Recruiting |
| Maryland Oncology Hematology | Silver Spring, Maryland, United States | Recruiting |
| Karmanos Cancer Center | Detroit, Michigan, United States | Recruiting |
| Duke University | Durham, North Carolina, United States | Recruiting |
| Novant Health Cancer Institute | Winston-Salem, North Carolina, United States | Recruiting |
| University of Cincinnati | Cincinnati, Ohio, United States | Recruiting |
+ 20 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07221500